Download Medical Notes on Indian API (Active Pharmaceutical Ingredient) Industry

Indian API (Active Pharmaceutical Ingredient) Industry - Reaching The Full Potential Medical Notes

About This Presentation

Description:The pharma industry in India is the world’s third largest if we talk about volume, and is thirteenth largest in terms of value. The pharmaceutical industry in India generates over USD11 billion of trade surplus every year. The industry is among the top 5 sectors contributing to the curtailing of India’s trade deficit. This report by CII in partnership with KPMG tries to encompass the present state of the Indian bulk drug industry, identifies challenges threatening the industry, compares Indian pharma industry with Chinese pharma industry and proposes recommendations to help India establish self-sufficiency in APIs. With an intent to help India establish self-sufficiency and export prowess in the API segment, the recommendations proposed in this report have been constructed around – • Providing ease of doing business • Incentives and subsidies • Infrastructure development and innova

Tags:Indian API, pharma industry, Indian pharma industry, CII, KPMG, Chinese pharma industry, bulk drug industry

Published on: Jun 30, 2020 | Views : 2166 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

Managed Care Models: The Benefit vs. Cost Balance

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

Managed Care Models: The Benefit vs. Cost Balance

A Blueprint for Improving the Security of the USA Pharmaceutical Supply Chain

Deloitte's 2019 Global health care outlook

Specialty Pharmacy and Biosimilars

EvaluatePharma Orphan Drug Report 2020

COVID-19: Super-charging Drug Development in the Race for a Cure

Granulation

A Blueprint for Improving the Security of the USA Pharmaceutical Supply Chain

Global Medicine Spending and Usage Trends - Outlook to 2024

Emerging Biopharma’s Contribution to Innovation

HEALTH A TO Z